{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:06:56Z","timestamp":1790996816107,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2017\/27\/B\/NZ3\/02212"],"award-info":[{"award-number":["UMO-2017\/27\/B\/NZ3\/02212"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institute of Biochemistry and Biophysics of the Polish Academy of Sciences","award":["PNO-09"],"award-info":[{"award-number":["PNO-09"]}]},{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada\u0144 i Rozwoju","doi-asserted-by":"publisher","award":["NCRD - PBS1\/B7\/7\/2012"],"award-info":[{"award-number":["NCRD - PBS1\/B7\/7\/2012"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genistein is applied worldwide as an alternative medicament for psoriasis (Ps) because of its anti-inflammatory activity and perceived beneficial impact on the skin. Hereby, we report our in vivo and in vitro investigations to supplement scientific research in this area. The reduction of clinical and biochemical scores in mild to moderate Ps patients taking genistein, its safety, good tolerability with no serious adverse events or discontinuations of treatment, no dose-limiting toxicities, negligible changes in pharmacodynamic parameters and remarkable serum interleukin level alterations were documented in this study. A certain regression of the Ps phenotype was visible, based on photo-documented Ps lesion evaluation. Through in vitro experiments, we found that genistein reduced IL-17A and TNF-\u03b1 induced MAPK, NF-\u03baB, and PI3K activation in normal human epidermal keratinocytes. Moreover, at the mRNA level of genes associated with the early inflammatory response characteristic for Ps (<jats:italic>CAMP<\/jats:italic>, <jats:italic>CCL20<\/jats:italic>, <jats:italic>DEFB4A<\/jats:italic>, <jats:italic>PIK3CA<\/jats:italic>, <jats:italic>S100A7<\/jats:italic>, and <jats:italic>S100A9<\/jats:italic>) and key cellular signalling (<jats:italic>MTORC1<\/jats:italic> and <jats:italic>TFEB<\/jats:italic>), we showed that this isoflavone attenuated the increased response of IL-17A- and TNF-\u03b1-related pathways. This allows us to conclude that genistein is a good candidate for Ps treatment, being attractive for co-pharmacotherapy with other drugs.<\/jats:p>","DOI":"10.1038\/s41598-021-97793-4","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T10:03:16Z","timestamp":1631613796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impact of isoflavone genistein on psoriasis in in vivo and in vitro investigations"],"prefix":"10.1038","volume":"11","author":[{"given":"Katarzyna","family":"Boche\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Moskot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elwira","family":"Smoli\u0144ska-Fijo\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jak\u00f3bkiewicz-Banecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Szczerkowska-Dobosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"S\u0142omi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Gabig-Cimi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"97793_CR1","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.3390\/ijms18122526","volume":"18","author":"F Capon","year":"2017","unstructured":"Capon, F. The genetic basis of psoriasis. Int. J. Mol. Sci. 18, 2526. https:\/\/doi.org\/10.3390\/ijms18122526 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"97793_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fmed.2016.00046","volume":"3","author":"S K\u00f5ks","year":"2016","unstructured":"K\u00f5ks, S. et al. Psoriasis-specific RNA isoforms identified by RNA-seq analysis of 173,446 transcripts. Front. Med. 3, 46. https:\/\/doi.org\/10.3389\/fmed.2016.00046 (2016).","journal-title":"Front. Med."},{"key":"97793_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/er.2012-1092","volume":"34","author":"AT Slominski","year":"2013","unstructured":"Slominski, A. T. et al. Key role of CRF in the skin stress response system. Endocr. Rev. 34, 827\u2013884 (2013).","journal-title":"Endocr. Rev."},{"key":"97793_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.mce.2021.111238","volume":"15","author":"RM Slominski","year":"2021","unstructured":"Slominski, R. M. et al. The significance of CYP11A1 expression in skin physiology and pathology. Mol. Cell. Endocrinol. 15, 530. https:\/\/doi.org\/10.1016\/j.mce.2021.111238 (2021).","journal-title":"Mol. Cell. Endocrinol."},{"key":"97793_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","volume":"201","author":"JE Hawkes","year":"2018","unstructured":"Hawkes, J. E., Yan, B. Y., Chan, T. C. & Krueger, J. G. Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. J. Immunol. 201, 1605\u20131613 (2018).","journal-title":"J. Immunol."},{"key":"97793_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths, C. E. & Barker, J. N. Pathogenesis and clinical features of psoriasis. Lancet 370, 263\u2013271 (2007).","journal-title":"Lancet"},{"key":"97793_CR7","first-page":"1092","volume":"159","author":"KE Nograles","year":"2008","unstructured":"Nograles, K. E. et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159, 1092\u20131102 (2008).","journal-title":"Br. J. Dermatol."},{"key":"97793_CR8","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.20150204","volume":"212","author":"L Wu","year":"2015","unstructured":"Wu, L. et al. A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis. J. Exp. Med. 212, 1571\u20131587 (2015).","journal-title":"J. Exp. Med."},{"key":"97793_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2010.340","volume":"131","author":"A Chiricozzi","year":"2011","unstructured":"Chiricozzi, A. et al. Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J. Invest. Dermatol. 131, 677\u2013687 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"97793_CR10","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A. W. & Read, C. Pathophysiology, clinical presentation, and treatment of psoriasis: A review. JAMA 323, 1945\u20131960 (2020).","journal-title":"JAMA"},{"key":"97793_CR11","first-page":"111","volume":"23","author":"JD Bahner","year":"2009","unstructured":"Bahner, J. D., Cao, L. Y. & Korman, N. J. Biologics in the management of psoriasis. Clin. Cosmet. Investig. Dermatol. 23, 111\u2013128 (2009).","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"97793_CR12","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1111\/bjd.15610","volume":"177","author":"CEM Griffiths","year":"2017","unstructured":"Griffiths, C. E. M. et al. The global state of psoriasis disease epidemiology: A workshop report. Br. J. Dermatol. 177, e4\u2013e7. https:\/\/doi.org\/10.1111\/bjd.15610 (2017).","journal-title":"Br. J. Dermatol."},{"key":"97793_CR13","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/jid.2010.103","volume":"130","author":"BB Davidovici","year":"2010","unstructured":"Davidovici, B. B. et al. Psoriasis and systemic inflammatory diseases: Potential mechanistic links between skin disease and co-morbid conditions. J. Invest. Dermatol. 130, 1785\u20131796 (2010).","journal-title":"J. Invest. Dermatol."},{"key":"97793_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4161\/oxim.2.5.9498","volume":"5","author":"KB Pandey","year":"2009","unstructured":"Pandey, K. B. & Rizvi, S. I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell Longev. 5, 270\u2013278 (2009).","journal-title":"Oxid. Med. Cell Longev."},{"key":"97793_CR15","doi-asserted-by":"publisher","first-page":"e20924","DOI":"10.17795\/jjnpp-20924","volume":"10","author":"N Pazyar","year":"2015","unstructured":"Pazyar, N. & Yaghoobi, R. Soybean: A potential antipsoriasis agent. Jundishapur J. Nat. Pharm. Prod. 10, e20924. https:\/\/doi.org\/10.17795\/jjnpp-20924 (2015).","journal-title":"Jundishapur J. Nat. Pharm. Prod."},{"key":"97793_CR16","first-page":"101","volume":"66","author":"E Smoli\u0144ska","year":"2019","unstructured":"Smoli\u0144ska, E., W\u0119grzyn, G. & Gabig-Cimi\u0144ska, M. Genistein modulates gene activity in psoriatic patients. Acta Biochim. Pol. 66, 101\u2013110 (2019).","journal-title":"Acta Biochim. Pol."},{"key":"97793_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.intimp.2019.01.054","volume":"69","author":"A Wang","year":"2019","unstructured":"Wang, A. et al. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-\u03baB-dependent mechanism in keratinocytes. Int. Immunopharmacol. 69, 270\u2013278 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"97793_CR18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/nu9060622","volume":"6","author":"N Irrera","year":"2017","unstructured":"Irrera, N. et al. Dietary management of skin health: The role of genistein. Nutrients 6, 622. https:\/\/doi.org\/10.3390\/nu9060622 (2017).","journal-title":"Nutrients"},{"key":"97793_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.critrevonc.2017.09.004","volume":"119","author":"V Mukund","year":"2017","unstructured":"Mukund, V., Mukund, D., Sharma, V., Mannarapu, M. & Alam, A. Genistein: Its role in metabolic diseases and cancer. Crit. Rev. Oncol. Hematol. 119, 13\u201322 (2017).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"97793_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.biopha.2016.05.023","volume":"82","author":"MA Rahman Mazumder","year":"2016","unstructured":"Rahman Mazumder, M. A. & Hongsprabhas, P. Genistein as antioxidant and antibrowning agents in in vivo and in vitro: A review. Biomed. Pharmacother. 82, 379\u2013392 (2016).","journal-title":"Biomed. Pharmacother."},{"key":"97793_CR21","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/ajcn\/76.5.1126","volume":"76","author":"LT Bloedon","year":"2002","unstructured":"Bloedon, L. T. et al. Safety and pharmacokinetics of purified soy isoflavones: Single-dose administration to postmenopausal women. Am. J. Clin. Nutr. 76, 1126\u20131137 (2002).","journal-title":"Am. J. Clin. Nutr."},{"key":"97793_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijpharm.2008.08.002","volume":"364","author":"ZR Huang","year":"2008","unstructured":"Huang, Z. R., Hung, C. F., Lin, Y. K. & Fang, J. Y. In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein. Int. J. Pharm. 364, 36\u201344 (2008).","journal-title":"Int. J. Pharm."},{"key":"97793_CR23","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3390\/molecules24081589","volume":"24","author":"S Sung","year":"2019","unstructured":"Sung, S., Kwon, D., Um, E. & Kim, B. Could polyphenols help in the control of rheumatoid arthritis?. Molecules 24, 1589. https:\/\/doi.org\/10.3390\/molecules24081589 (2019).","journal-title":"Molecules"},{"key":"97793_CR24","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3390\/ijms17060921","volume":"17","author":"N Leyva-L\u00f3pez","year":"2016","unstructured":"Leyva-L\u00f3pez, N., Gutierrez-Grijalva, E. P., Ambriz-Perez, D. L. & Heredia, J. B. Flavonoids as cytokine modulators: A possible therapy for inflammation-related diseases. Int. J. Mol. Sci. 17, 921. https:\/\/doi.org\/10.3390\/ijms17060921 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"97793_CR25","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.3390\/ijms18122514","volume":"18","author":"K Boche\u0144ska","year":"2017","unstructured":"Boche\u0144ska, K., Smoli\u0144ska, E., Moskot, M., Jak\u00f3bkiewicz-Banecka, J. & Gabig-Cimi\u0144ska, M. Models in the research process of psoriasis. Int. J. Mol. Sci. 18, 2514. https:\/\/doi.org\/10.3390\/ijms18122514 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"97793_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/ijms19010247","volume":"19","author":"M Moskot","year":"2018","unstructured":"Moskot, M., Boche\u0144ska, K., Jak\u00f3bkiewicz-Banecka, J., Banecki, B. & Gabig-Cimi\u0144ska, M. Abnormal sphingolipid world in inflammation specific for lysosomal storage diseases and skin disorders. Int. J. Mol. Sci. 19, 247. https:\/\/doi.org\/10.3390\/ijms19010247 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"97793_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1254\/fpj.99.55","volume":"99","author":"K Ito","year":"1992","unstructured":"Ito, K., Namikawa, S. & Takeuchi, K. Effect of the dry distillation tar of delipidated soybean (Glyteer) on a psoriasic model in the mouse. Nihon Yakurigaku Zasshi. 99, 55\u201362 (1992).","journal-title":"Nihon Yakurigaku Zasshi."},{"key":"97793_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/carcin\/23.2.317","volume":"23","author":"EQ Shyong","year":"2002","unstructured":"Shyong, E. Q. et al. Effects of the isoflavone 4\u2019,5,7-trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamage. Carcinogenesis 23, 317\u2013321 (2002).","journal-title":"Carcinogenesis"},{"key":"97793_CR29","doi-asserted-by":"publisher","first-page":"e0192297","DOI":"10.1371\/journal.pone.0192297","volume":"13","author":"E Smoli\u0144ska","year":"2018","unstructured":"Smoli\u0144ska, E. et al. Molecular action of isoflavone genistein in the human epithelial cell line HaCaT. PLoS ONE 13, e0192297. https:\/\/doi.org\/10.1371\/journal.pone.0192297 (2018).","journal-title":"PLoS ONE"},{"key":"97793_CR30","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1038\/s41598-018-24726-z","volume":"8","author":"HJ Li","year":"2018","unstructured":"Li, H. J., Wu, N. L., Lee, G. A. & Hung, C. F. The therapeutic potential and molecular mechanism of isoflavone extract against psoriasis. Sci. Rep. 8, 6335. https:\/\/doi.org\/10.1038\/s41598-018-24726-z (2018).","journal-title":"Sci. Rep."},{"key":"97793_CR31","doi-asserted-by":"publisher","first-page":"e0199631","DOI":"10.1371\/journal.pone.0199631","volume":"13","author":"JD Abron","year":"2018","unstructured":"Abron, J. D. et al. Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis. PLoS ONE 13, e0199631. https:\/\/doi.org\/10.1371\/journal.pone.0199631 (2018).","journal-title":"PLoS ONE"},{"key":"97793_CR32","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.fct.2007.01.009","volume":"45","author":"RM McClain","year":"2007","unstructured":"McClain, R. M., Wolz, E., Davidovich, A., Edwards, J. & Bausch, J. Reproductive safety studies with genistein in rats. Food Chem. Toxicol. 45, 1319\u20131332 (2007).","journal-title":"Food Chem. Toxicol."},{"key":"97793_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cyto.2017.10.008","volume":"104","author":"SM Mirahmadi","year":"2018","unstructured":"Mirahmadi, S. M. et al. Soy isoflavone genistein attenuates lipopolysaccharide-induced cognitive impairments in the rat via exerting anti-oxidative and anti-inflammatory effects. Cytokine 104, 151\u2013159 (2018).","journal-title":"Cytokine"},{"key":"97793_CR34","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/ajcn\/77.2.411","volume":"77","author":"K Setchell","year":"2003","unstructured":"Setchell, K. et al. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am. J. Clin. Nutr. 77, 411\u2013419 (2003).","journal-title":"Am. J. Clin. Nutr."},{"key":"97793_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.intimp.2018.04.018","volume":"59","author":"P Li","year":"2018","unstructured":"Li, P. et al. Glabridin, an isoflavan from licorice root, ameliorates imiquimod-induced psoriasis-like inflammation of BALB\/c mice. Int. Immunopharmacol. 59, 243\u2013251 (2018).","journal-title":"Int. Immunopharmacol."},{"key":"97793_CR36","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1159\/000373955","volume":"35","author":"H Xiong","year":"2015","unstructured":"Xiong, H. et al. Glycyrrhizin ameliorates imiquimod induced psoriasis-like skin lesions in BALB\/c mice and inhibits TNF-alpha-induced ICAM-1 expression via NF-kappaB\/MAPK in HaCaT cells. Cell. Physiol. Biochem. 35, 1335\u20131346 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"97793_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/ars.2016.6769","volume":"26","author":"JC Chamcheu","year":"2017","unstructured":"Chamcheu, J. C. et al. Dual inhibition of PI3K\/Akt and mTOR by the dietary antioxidant, delphinidin, ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like disease in mice. Antioxid. Redox. Signal. 26, 49\u201369 (2017).","journal-title":"Antioxid. Redox. Signal."},{"key":"97793_CR38","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/ajcn\/80.3.692","volume":"80","author":"H Wiseman","year":"2004","unstructured":"Wiseman, H. et al. Influence of 10 week of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am. J. Clin. Nutr. 80, 692\u2013699 (2004).","journal-title":"Am. J. Clin. Nutr."},{"key":"97793_CR39","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jpba.2006.01.051","volume":"41","author":"J Mathey","year":"2006","unstructured":"Mathey, J. et al. Concentrations of isoflavones in plasma and urine of post-menopausal women chronically ingesting high quantities of soy isoflavones. J. Pharm. Biomed. Anal. 41, 957\u2013965 (2006).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"97793_CR40","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1001\/jama.2015.5024","volume":"313","author":"R Kalhan","year":"2015","unstructured":"Kalhan, R. et al. American Lung Association Asthma Clinical Research Centers. Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: A randomized clinical trial. JAMA 313, 2033\u20132043 (2015).","journal-title":"JAMA"},{"key":"97793_CR41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1042\/bst0270304","volume":"27","author":"I Rowland","year":"1999","unstructured":"Rowland, I., Wiseman, H., Sanders, T., Adlercreutz, H. & Bowey, E. Metabolism of oestrogens and phytoestrogens: Role of the gut microflora. Biochem. Soc. Trans. 27, 304\u2013308 (1999).","journal-title":"Biochem. Soc. Trans."},{"key":"97793_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/jn\/136.1.45","volume":"136","author":"A Cassidy","year":"2006","unstructured":"Cassidy, A. et al. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J. Nut. 136, 45\u201351 (2006).","journal-title":"J. Nut."},{"key":"97793_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01635580701267677","volume":"57","author":"IL Nielsen","year":"2007","unstructured":"Nielsen, I. L. & Williamson, G. Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr. Cancer. 57, 1\u201310 (2007).","journal-title":"Nutr. Cancer."},{"key":"97793_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3945\/jn.111.148247","volume":"142","author":"A Matthies","year":"2012","unstructured":"Matthies, A., Loh, G., Blaut, M. & Braune, A. Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats. J. Nutr. 142, 40\u201346 (2012).","journal-title":"J. Nutr."},{"key":"97793_CR45","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.3390\/ijms20092255","volume":"9","author":"K Bochenska","year":"2019","unstructured":"Bochenska, K. et al. Lysosome alterations in the human epithelial cell line HaCaT and skin specimens: Relevance to psoriasis. Int. J. Mol. Sci. 9, 2255. https:\/\/doi.org\/10.3390\/ijms20092255 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"97793_CR46","doi-asserted-by":"publisher","first-page":"17054","DOI":"10.1074\/jbc.M114.555300","volume":"289","author":"M Moskot","year":"2014","unstructured":"Moskot, M. et al. The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activation. J. Biol. Chem. 289, 17054\u201317069 (2014).","journal-title":"J. Biol. Chem."},{"key":"97793_CR47","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/ijd.12050","volume":"53","author":"N Moorchung","year":"2014","unstructured":"Moorchung, N. et al. Role of NF-\u03baB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens. Int. J. Dermatol. 53, 570\u2013574 (2014).","journal-title":"Int. J. Dermatol."},{"key":"97793_CR48","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","volume":"139","author":"F Kolbinger","year":"2017","unstructured":"Kolbinger, F. et al. \u03b2-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis. J. Allergy Clin. Immunol. 139, 923\u2013932 (2017).","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97793-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97793-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97793-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:26:59Z","timestamp":1670081219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97793-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["97793"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-97793-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]},"assertion":[{"value":"11 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18297"}}